Oracle Investment Management Has Boosted Position in Contrafect (CFRX) as Stock Value Declined; Axel Capital Management Cut Its Stake in Albemarle (ALB) by $2.57 Million

January 13, 2018 - By Nellie Frank

Oracle Investment Management Inc increased its stake in Contrafect Corp (CFRX) by 84.6% based on its latest 2017Q3 regulatory filing with the SEC. Oracle Investment Management Inc bought 1.00 million shares as the company’s stock declined 41.86% while stock markets rallied. The hedge fund held 2.18M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $2.42M, up from 1.18M at the end of the previous reported quarter. Oracle Investment Management Inc who had been investing in Contrafect Corp for a number of months, seems to be bullish on the $87.65 million market cap company. The stock increased 0.42% or $0.01 during the last trading session, reaching $1.19. About 42,570 shares traded. ContraFect Corporation (NASDAQ:CFRX) has declined 42.92% since January 13, 2017 and is downtrending. It has underperformed by 59.62% the S&P500.

Anna Nikolayevsky decreased its stake in Albemarle Corp (ALB) by 15.4% based on its latest 2017Q3 regulatory filing with the SEC. Axel Capital Management Llc sold 18,928 shares as the company’s stock rose 20.02% with the market. The hedge fund run by Anna Nikolayevsky held 104,000 shares of the major chemicals company at the end of 2017Q3, valued at $14.18 million, down from 122,928 at the end of the previous reported quarter. Axel Capital Management Llc who had been investing in Albemarle Corp for a number of months, seems to be less bullish one the $14.75 billion market cap company. The stock decreased 0.87% or $1.17 during the last trading session, reaching $133.52. About 990,097 shares traded. Albemarle Corporation (NYSE:ALB) has risen 45.60% since January 13, 2017 and is uptrending. It has outperformed by 28.90% the S&P500.

Among 3 analysts covering ContraFect (NASDAQ:CFRX), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. ContraFect had 5 analyst reports since December 31, 2015 according to SRatingsIntel. The rating was downgraded by Maxim Group on Friday, July 22 to “Buy”. Roth Capital downgraded the shares of CFRX in report on Tuesday, May 10 to “Neutral” rating. The firm earned “Buy” rating on Thursday, December 31 by Maxim Group. The stock has “Outperform” rating by William Blair on Wednesday, September 28.

Oracle Investment Management Inc, which manages about $877.33M and $609.65M US Long portfolio, decreased its stake in Accelerate Diagnostics Inc (Call) by 4.26 million shares to 458,800 shares, valued at $897,000 in 2017Q3, according to the filing. It also reduced its holding in Tesaro Inc (Call) (NASDAQ:TSRO) by 376,400 shares in the quarter, leaving it with 100,000 shares, and cut its stake in Amarin Corp Plc (NASDAQ:AMRN).

Analysts await Albemarle Corporation (NYSE:ALB) to report earnings on February, 26. They expect $1.21 earnings per share, up 55.13% or $0.43 from last year’s $0.78 per share. ALB’s profit will be $133.70M for 27.59 P/E if the $1.21 EPS becomes a reality. After $1.08 actual earnings per share reported by Albemarle Corporation for the previous quarter, Wall Street now forecasts 12.04% EPS growth.

Investors sentiment decreased to 1.13 in 2017 Q3. Its down 0.12, from 1.25 in 2017Q2. It turned negative, as 53 investors sold ALB shares while 158 reduced holdings. 77 funds opened positions while 161 raised stakes. 95.18 million shares or 4.66% more from 90.94 million shares in 2017Q2 were reported. 7,949 are held by Rathbone Brothers Public Ltd Com. Moreover, Exane Derivatives has 0% invested in Albemarle Corporation (NYSE:ALB). New York-based State Common Retirement Fund has invested 0.06% in Albemarle Corporation (NYSE:ALB). Robeco Institutional Asset Bv holds 272,561 shares or 0.23% of its portfolio. Tiemann Advisors Ltd Llc has 4,368 shares. Moreover, Credit Agricole S A has 0.02% invested in Albemarle Corporation (NYSE:ALB) for 53,222 shares. Monetta Fin Service Inc has 0.78% invested in Albemarle Corporation (NYSE:ALB) for 10,500 shares. 29,860 were reported by Gamco Investors Et Al. Rothschild Il has invested 0.12% of its portfolio in Albemarle Corporation (NYSE:ALB). Bnp Paribas Arbitrage Sa has invested 0.02% in Albemarle Corporation (NYSE:ALB). Sentry Invests, Ontario – Canada-based fund reported 28,000 shares. Swiss Bancshares holds 0.06% or 409,606 shares. Envestnet Asset owns 39,135 shares or 0.01% of their US portfolio. Deutsche Commercial Bank Ag holds 0.11% of its portfolio in Albemarle Corporation (NYSE:ALB) for 1.19 million shares. Raymond James Tru Na accumulated 0.04% or 3,890 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>